Basics Genelux Corporation Common Stock IPO Date: January 26, 2023 Sector: Healthcare Industry: Biotech Market Cap: $253.84M Activated in VL: True Average Daily Range Avg Daily Range: $0.52 | 4.91% Avg Daily Range (30 D): $0.21 | 4.23% Avg Daily Range (90 D): $0.16 | 3.99% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .16M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 116 Avg Trade Size (Sh.) (90 D): 130 Institutional Trades Total Inst.Trades: 28 Avg Inst. Trade: $3.48M Avg Inst. Trade (30 D): $1.08M Avg Inst. Trade (90 D): $1.19M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.61M Avg Closing Trade (30 D): $3.23M Avg Closing Trade (90 D): $3.23M Avg Closing Volume: 413.66K     News Sep 3, 2024 @ 8:01 PM Genelux Corporation to Present at the H.C. Wainwri... Source: N/A Jul 30, 2024 @ 11:00 AM Genelux Corporation to Participate in Fireside Cha... Source: N/A May 31, 2024 @ 4:01 PM Unveiling 4 Analyst Insights On Genelux Source: Benzinga Insights May 24, 2024 @ 12:00 PM Genelux Corporation Announces Pricing of Approxima... Source: Genelux Corporation May 23, 2024 @ 8:01 PM Genelux Corporation Announces Proposed Public Offe... Source: Genelux Corporation Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.86 $-.2 $-.21 Diluted EPS $-.86 $-.2 $-.21 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -30.39M $ -7.46M $ -7.49M Operating Income / Loss $ -32.3M $ -7.79M $ -7.82M Cost of Revenue $ $ $ Net Cash Flow $ -1.31M $ -9.66M $ 7.64M PE Ratio